Focal Points

Brom Rector and Focalpoint Partners
  • 5,0 (5)
  • TECHNOLOGIES
Focal Points

Focal Points is the official podcast of Focalpoint Partners. Focalpoint Partners is a venture capital fund that catalyzes healthcare breakthroughs by aligning people, technology and capital.

Épisodes

  1. 30 SEPT.

    Making Deep Brain Stimulation Minimally Invasive with MJ Antonini and Nicki Driscoll of NeuroBionics

    Today’s guests are MJ Antonini & Nicki Driscoll, the founders of NeuroBionics, a neurotech startup out of MIT. NeuroBionics is making Deep Brain Stimulation minimally invasive though the development of nano fibers that are 10X thinner than traditional Deep Brain Stimulation leads - allowing them to be inserted endovascularly into the brain. Check out NeuroBionics at https://neurobionics.io/

    55 min
  2. Advancements in Male Sexual Health w/ John Boghossian & Ryan Protzko of Kadence Bio

    30 AVR.

    Advancements in Male Sexual Health w/ John Boghossian & Ryan Protzko of Kadence Bio

    Can a succulent plant from South Africa treat premature ejaculation? John Boghossian and Dr Ryan Protzko from Kadence Bio think so. www.kadencebio.com

    1 h

  3. 23/10/2023

    Can Skull Implants Treat Depression? Jacob Robinson & Motif Neurotech (Crossover Episode on Business Trip)

    Can brain implants treat your depression? Ok, technically this would be a skull implant, not a brain implant - but still! Jacob Robinson from Motif Neurotech discusses the future of minimally invasive electronic medicine from mental health and beyond. This is a crossover episode from the Business Trip podcast.

    55 min
  4. Sam Banister - The Art and Science of Designing Novel Psychoactive Therapeutics

    30/06/2022

    Sam Banister - The Art and Science of Designing Novel Psychoactive Therapeutics

    Sam Banister is a medicinal chemist and co-founder of Psylo.  Psylo is an Australian psychedelic biotech company using machine learning assisted drug design techniques to developing novel psychedelic medicines to treat mental illness.    Sam is here to help us understand how new chemical entities are reshaping the psychedelic field; how novel psychedelic molecules are made,  and how new chemical entities are going to play a dominant role in the future of psychedelic medicine.   Make sure to subscribe to the show!   Follow Brom on twitter: https://twitter.com/therealbrom Follow Sam on twitter: https://twitter.com/samuel_b_phd Brom's VC Fund:  https://www.empath.vc Highlighted Timestamps:   06:12 - Are next generation psychedelics taking over in 10 years?   16:10 - What is the process like for creating a new chemical entities?   50:39 - Psychedelics vs Cannabis: New drug discoveries

    1 h 1 min
  5. Tom Feegel, CEO of Beond - Ending the Opiate Addiction Epidemic with Safe Ibogaine Treatment

    27/03/2022

    Tom Feegel, CEO of Beond - Ending the Opiate Addiction Epidemic with Safe Ibogaine Treatment

    Tom Feegel is the Founder and CEO of Beond.  Beond exists to help end the opiate addiction epidemic with safe ibogaine treatment.   In this episode Tom speaks on the severity of the opioid epidemic and explains how ibogaine assisted therapy can help heal those who are suffering from addiction.  Tom gets into his personal story, how Ibogaine helped someone in his family, the economics of addiction treatment and Beond's plans to scale into a global operation.     https://www.beond.us

    58 min
  6. Dillan DiNardo - CEO of Mindstate Design Labs | Creating Novel Psychoactive Drugs at Y Combinator

    10/02/2022

    Dillan DiNardo - CEO of Mindstate Design Labs | Creating Novel Psychoactive Drugs at Y Combinator

    Dillan DiNardo is the CEO of Mindstate Design Labs - a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics for intractable mental health conditions.   Mindstate's mission is to map the biological basis of the varieties of psychedelic experience, and to use that map to pharmacologically design therapeutic states of mind to be applied in medically supervised settings to heal the root causes of mental health disorders.  Mindstate participated in Y Combinator in 2021.    Check out Mindstate @ https://www.mindstate.design/

    42 min
  • 6 épisodes

Notes et avis

5
sur 5
5 notes

À propos

Focal Points is the official podcast of Focalpoint Partners. Focalpoint Partners is a venture capital fund that catalyzes healthcare breakthroughs by aligning people, technology and capital.

Informations

  • Création
    Brom Rector and Focalpoint Partners
  • Années d’activité
    2021 - 2024
  • Épisodes
    6
  • Classification
    Contenu explicite
  • Copyright
    © Brom Rector and Focalpoint Partners
  • Site web de l’émission
    Focal Points

Vous aimeriez peut‑être aussi

Pour écouter des épisodes au contenu explicite, connectez‑vous.

Recevez les dernières actualités sur cette émission

Connectez‑vous ou inscrivez‑vous pour suivre des émissions, enregistrer des épisodes et recevoir les dernières actualités.
Choisissez un pays ou une région

Afrique, Moyen‑Orient et Inde

Asie‑Pacifique

Europe

Amérique latine et Caraïbes

États‑Unis et Canada